CryoCath Technologies 

CryoCath is a medical technology company that leads the world in creating catheter and probe-based CryoTherapy products to treat cardiovascular disease. Traditionnaly, the use of freezing temperatures to treat diseased tissue has been limited by the inability to deliver the treatment in a minimally invasive manner. Cryocath has successfully overcome this obstacle by developing flexible, steerable, minimally invasive catheters to deliver cold therapy safely and effectively.

CryoCath is a public company based in Montréal and is listed on the Toronto Stock Exchange (TSX CYT)

SGF participation: 8% 

www.cryocath.com